Skip to main content
NCBI home page
International Journal of Methods in Psychiatric Research logoLink to International Journal of Methods in Psychiatric Research
. 2008 Sep 3;17(3):121–140. doi: 10.1002/mpr.256

The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods

Brenda WJH Penninx 1,2,3,✉, Aartjan TF Beekman 1, Johannes H Smit 1, Frans G Zitman 2, Willem A Nolen 3, Philip Spinhoven 4, Pim Cuijpers 5, Peter J De Jong 6, Harm WJ Van Marwijk 7, Willem JJ Assendelft 8, Klaas Van Der Meer 9, Peter Verhaak 10, Michel Wensing 11, Ron De Graaf 12, Witte J Hoogendijk 1, Johan Ormel 3, Richard Van Dyck 1
PMCID: PMC6878352  PMID: 18763692

Abstract

The Netherlands Study of Depression and Anxiety (NESDA) is a multi‐site naturalistic cohort study to: (1) describe the long‐term course and consequences of depressive and anxiety disorders, and (2) to integrate biological and psychosocial research paradigms within an epidemiological approach in order to examine (interaction between) predictors of the long‐term course and consequences.

Its design is an eight‐year longitudinal cohort study among 2981 participants aged 18 through 65 years. The sample consists of 1701 persons with a current (six‐month recency) diagnosis of depression and/or anxiety disorder, 907 persons with life‐time diagnoses or at risk because of a family history or subthreshold depressive or anxiety symptoms, and 373 healthy controls. Recruitment took place in the general population, in general practices (through a three‐stage screening procedure), and in mental health organizations in order to recruit persons reflecting various settings and developmental stages of psychopathology. During a four‐hour baseline assessment including written questionnaires, interviews, a medical examination, a cognitive computer task and collection of blood and saliva samples, extensive information was gathered about key (mental) health outcomes and demographic, psychosocial, clinical, biological and genetic determinants. Detailed assessments will be repeated after one, two, four and eight years of follow‐up.

The findings of NESDA are expected to provide more detailed insight into (predictors of) the long‐term course of depressive and anxiety disorders in adults. Besides its scientific relevance, this may contribute to more effective prevention and treatment of depressive and anxiety disorders. Copyright © 2008 John Wiley & Sons, Ltd.

Keywords: depressive disorder, anxiety disorder, course, epidemiology, longitudinal studies

Full Text

The Full Text of this article is available as a PDF (334.7 KB).

REFERENCES

  1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, De Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh‐bouchez S, Autonell J, Bernal M, Buist‐Bouwman MA, Codony M, Domingo‐Salvany A, Ferrer M, Joo SS, Martinez‐Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WAM (2004). Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420: 47–54. [DOI] [PubMed] [Google Scholar]
  2. American Psychiatric Association (2001). Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Washington, DC: American Psychiatric Publishing. [Google Scholar]
  3. Anand A, Shekhar A (2003). Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann NY Acad Sci 985: 370–88. [DOI] [PubMed] [Google Scholar]
  4. Andrade L, Caraveo‐Anduaga JJ, Berglund P, Bijl RB, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC, Kawakami N, Kilic C, Offord D, Ustun TB, Wittchen HU (2003). The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys. Int J Methods Psychiatr Res 12: 3–21. DOI 10.1002/mpr.138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Andrews JS, Stephens DN (1990). Drug discrimination models in anxiety and depression. Pharmacol Ther 47: 267–80. [DOI] [PubMed] [Google Scholar]
  6. Angst J (1996). Comorbidity of mood disorders: a longitudinal prospective study. Br J Psychiatry Suppl 31–7. [PubMed] [Google Scholar]
  7. Babor TF, Kranzler HR, Lauerman RJ (1989). Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self‐report screening procedures. Addict Behav 14: 139–57. [DOI] [PubMed] [Google Scholar]
  8. Beck AT, Kovacs M, Weissman A (1979). Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 47: 343–52. [DOI] [PubMed] [Google Scholar]
  9. Beck AT, Epstein N, Brown G, Steer RA (1988). An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893–7. [DOI] [PubMed] [Google Scholar]
  10. Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, Van DR, Van TW (2000). Anxiety and depression in later life: Co‐occurrence and communality of risk factors. Am J Psychiatry 157: 89–95. [DOI] [PubMed] [Google Scholar]
  11. Bijl RV, Ravelli A (2000). Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study. Am J Public Health 90: 602–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bijl RV, van ZG, Ravelli A, de RC, Langendoen Y (1998). The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 33: 581–86. [DOI] [PubMed] [Google Scholar]
  13. Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, SonderVan D, Kluft C, Smit G, Nolen WA, Zitman FG, Smit JH, Hoogendijk WJ, Van Dyck R, De Geus EJ, Penninx BW (2008). Genome‐wide association of Major Depression: Description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet 16: 335–42. [DOI] [PubMed] [Google Scholar]
  14. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR (1996). Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 153: 1293–300. [DOI] [PubMed] [Google Scholar]
  15. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12‐year prospective study. Am J Psychiatry 162: 1179–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Brugha T, Bebbington P, Tennant C, Hurry J (1985). The list of threatening experiences: a subset of 12 life event categories with considerable long‐term contextual threat. Psychol Med 15: 189–94. [DOI] [PubMed] [Google Scholar]
  17. Buist‐Bouwman MA, de Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J (2006). Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand 113: 492–500. [DOI] [PubMed] [Google Scholar]
  18. Canli T, Cooney RE, Goldin P, Shah M, Sivers H, Thomason ME, Whitfield‐Gabrieli S, Gabrieli JD, Gotlib IH (2005). Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 16: 1267–70. [DOI] [PubMed] [Google Scholar]
  19. Carlson S, Martinkauppi S, Rama P, Salli E, Korvenoja A, Aronen HJ (1998). Distribution of cortical activation during visuospatial n‐back tasks as revealed by functional magnetic resonance imaging. Cereb Cortex 8: 743–52. [DOI] [PubMed] [Google Scholar]
  20. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5‐HTT gene. Science 301: 386–9. [DOI] [PubMed] [Google Scholar]
  21. Chwastiak LA, von Korff M (2003). Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol 56: 507–14. [DOI] [PubMed] [Google Scholar]
  22. Cooper‐Patrick L, Crum RM, Ford DE (1994). Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Med Care 32: 15–24. [DOI] [PubMed] [Google Scholar]
  23. Costa PT, McCrae RR (1995). Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess 64: 21–50. [DOI] [PubMed] [Google Scholar]
  24. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003). International physical activity questionnaire: 12‐country reliability and validity. Med Sci Sports Exerc 35: 1381–95. [DOI] [PubMed] [Google Scholar]
  25. Daselaar SM, Veltman DJ, Rombouts SA, Raaijmakers JG, Jonker C (2003). Neuroanatomical correlates of episodic encoding and retrieval in young and elderly subjects. Brain 126: 43–56. [DOI] [PubMed] [Google Scholar]
  26. de Geus EJ, Willemsen GH, Klaver CH, van Doornen LJ (1995). Ambulatory measurement of respiratory sinus arrhythmia and respiration rate. Biol Psychol 41: 205–27. [DOI] [PubMed] [Google Scholar]
  27. Deckersbach T, Dougherty DD, Rauch SL (2006). Functional imaging of mood and anxiety disorders. J Neuroimaging 16: 1–10. [DOI] [PubMed] [Google Scholar]
  28. de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J (2002). Risk factors for 12‐month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 159: 620–9. [DOI] [PubMed] [Google Scholar]
  29. de Jong Gierveld J, Kamphuis (1985). The development of a rasch type loneliness scale. Appl Psychol Meas 9: 289–99. [Google Scholar]
  30. Duncan‐Jones P, Fergusson DM, Ormel J, Horwood LJ (1990). A model of stability and change in minor psychiatric symptoms: results from three longitudinal studies. Psychol Med Monogr Suppl 18: 1–28. [DOI] [PubMed] [Google Scholar]
  31. Eaton WW, Anthony JC, Gallo J, Cai G, Tien A, Romanoski A, Lyketsos C, Chen LS (1997). Natural history of Diagnostic Interview Schedule/DSM‐IV major depression. The Baltimore Epidemiologic Catchment Area follow‐up. Arch Gen Psychiatry 54: 993–9. [DOI] [PubMed] [Google Scholar]
  32. Furukawa TA, Kessler RC, Slade T, Andrews G (2003). The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well‐Being. Psychol Med 33: 357–62. [DOI] [PubMed] [Google Scholar]
  33. Fyer AJ, Weissman MM (1999). Genetic linkage study of panic: clinical methodology and description of pedigrees. Am J Med Genet 88: 173–81. [PubMed] [Google Scholar]
  34. Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, Ehlert U (2002). Low‐dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 64: 311–8. [DOI] [PubMed] [Google Scholar]
  35. Goldberg D (1996). A dimensional model for common mental disorders. Br J Psychiatry Suppl 44–9. [PubMed] [Google Scholar]
  36. Goldberg D, Huxley P (1992). Common mental disorders. London: Routledge. [Google Scholar]
  37. Greenwald AG, McGhee DE, Schwartz JL (1998). Measuring individual differences in implicit cognition: the implicit association test. J Pers Soc Psychol 74: 1464–80. [DOI] [PubMed] [Google Scholar]
  38. Hakkaart‐van Roijen L (2002). Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC‐P). Rotterdam: Institute for Medical Technology Assessment. [Google Scholar]
  39. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119–27. [DOI] [PubMed] [Google Scholar]
  40. Hecht H, von ZD, Wittchen HU (1990). Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord 18: 137–44. [DOI] [PubMed] [Google Scholar]
  41. Heim C, Newport DJ, Wagner D, Wilcox MM, Miller AH, Nemeroff CB (2002). The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety 15: 117–25. DOI:10.1002/da.10015 [DOI] [PubMed] [Google Scholar]
  42. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Jr, Lewis L , McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 157: 1873–5. [DOI] [PubMed] [Google Scholar]
  43. Judd LL (1997). The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry 54: 989–91. [DOI] [PubMed] [Google Scholar]
  44. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998). A prospective 12‐year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55: 694–700. [DOI] [PubMed] [Google Scholar]
  45. Kanner AD, Coyne JC, Schaefer C, Lazarus RS (1981). Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med 4: 1–39. [DOI] [PubMed] [Google Scholar]
  46. Karasek R, Brisson C, Kawakami N, Houtman I, Bongers P, Amick B (1998). The Job Content Questionnaire (JCQ): an instrument for internationally comparative assessments of psychosocial job characteristics. J Occup Health Psychol 3: 322–55. [DOI] [PubMed] [Google Scholar]
  47. Keller MB (2006). Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findings. J Clin Psychiatry Suppl 67(12): 14–9. [PubMed] [Google Scholar]
  48. Keller MB, Hanks DL (1993). Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 17: 551–70. [DOI] [PubMed] [Google Scholar]
  49. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J (1984). Long‐term outcome of episodes of major depression. Clinical and public health significance. JAMA 252: 788–92. [PubMed] [Google Scholar]
  50. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T (1992). Time to recovery, chronicity, and levels of psychopathology in major depression. A 5‐year prospective follow‐up of 431 subjects. Arch Gen Psychiatry 49: 809–16. [DOI] [PubMed] [Google Scholar]
  51. Kendler KS, Heath AC, Martin NG, Eaves LJ (1987). Symptoms of anxiety and symptoms of depression. Same genes, different environments? Arch Gen Psychiatry 44: 451–7. [DOI] [PubMed] [Google Scholar]
  52. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994). Lifetime and 12‐month prevalence of DSM‐III‐R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19. [DOI] [PubMed] [Google Scholar]
  53. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ. Normand SL, Manderscheid RW, Walters EE, Zaslavsky AM (2003). Screening for serious mental illness in the general population. Arch Gen Psychiatry 60: 184–9. [DOI] [PubMed] [Google Scholar]
  54. Koster EH, De Raedt R., Goeleven E, Franck E, Crombez G (2005). Mood‐congruent attentional bias in dysphoria: maintained attention to and impaired disengagement from negative information. Emotion 5: 446–55. [DOI] [PubMed] [Google Scholar]
  55. Krueger RF (1999). The structure of common mental disorders. Arch Gen Psychiatry 56: 921–6. [DOI] [PubMed] [Google Scholar]
  56. Landman‐Peeters KM, Hartman CA, van der PG, den Boer JA, Minderaa RB, Ormel J (2005). Gender differences in the relation between social support, problems in parent‐offspring communication, and depression and anxiety. Soc Sci Med 60: 2549–59. [DOI] [PubMed] [Google Scholar]
  57. Levine DW, Kripke DF, Kaplan RM, Lewis MA, Naughton MJ, Bowen DJ, Shumaker SA (2003). Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess 15: 137–48. [DOI] [PubMed] [Google Scholar]
  58. Lyketsos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW (1994). The life‐chart method to descibe the course of psychopathology. Int J Methods Psychiatr Res 4: 143–55. [Google Scholar]
  59. Marks IM, Mathews AM (1979). Brief standard self‐rating for phobic patients. Behav Res Ther 17: 263–7. [DOI] [PubMed] [Google Scholar]
  60. Meadows G, Harvey C, Fossey E, Burgess P (2000). Assessing perceived need for mental health care in a community survey: development of the Perceived Need for Care Questionnaire (PNCQ). Soc Psychiatry Psychiatr Epidemiol 35: 427–35. [DOI] [PubMed] [Google Scholar]
  61. Merikangas KR, Angst J, Eaton W, Canino G, Rubio‐Stipec M, Wacker H, Wittchen HU, Andrade L, Essau C, Whitaker A, Kraemer H, Robins LN, Kupfer DJ (1996). Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl 58–67. [PubMed] [Google Scholar]
  62. Merikangas KR, Chakravarti A, Moldin SO, Araj H, Blangero JC, Burmeister M, Crabbe J, Jr, Depaulo JR, Jr, Foulks E, Freimer NB, Koretz DS, Lichtenstein W, Mignot E, Reiss AL, Risch NJ, Takahashi JS (2002). Future of genetics of mood disorders research. Biol Psychiatry 52: 457–77. [DOI] [PubMed] [Google Scholar]
  63. Mersch PP, Vastenburg NC, Meesters Y, Bouhuys AL, Beersma DG, van den Hoofdakker RH, Den Boer JA (2004). The reliability and validity of the Seasonal Pattern Assessment Questionnaire: a comparison between patient groups. J Affect Disord 80: 209–19. [DOI] [PubMed] [Google Scholar]
  64. Meyer TJ, Miller ML, Metzger RL, Borkovec TD (1990). Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 28: 487–95. [DOI] [PubMed] [Google Scholar]
  65. Murray CJ, Lopez AD (1997). Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349: 1498–1504. [DOI] [PubMed] [Google Scholar]
  66. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK (1993). Ankle‐arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88: 837–45. [DOI] [PubMed] [Google Scholar]
  67. Okkes IM, Becker HW, Bernstein RM, Lamberts H (2002). The March 2002 update of the electronic version of ICPC‐2. A step forward to the use of ICD‐10 as a nomenclature and a terminology for ICPC‐2. Fam Pract 19: 543–6. [DOI] [PubMed] [Google Scholar]
  68. Ormel J, Von Korff M, Ustun TB, Pini S, Korten A, Oldehinkel T (1994). Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 272: 1741–8. [DOI] [PubMed] [Google Scholar]
  69. Oude Voshaar RC, Mol AJ, Gorgels WJ, Breteler MH, van Balkom AJ, Van De Lisdonk EH, Kan CC, Zitman FG (2003). Cross‐validation, predictive validity, and time course of the Benzodiazepine Dependence Self‐Report Questionnaire in a benzodiazepine discontinuation trial. Compr Psychiatry 44: 247–55. [DOI] [PubMed] [Google Scholar]
  70. Pearlin LI, Schooler C (1978). The structure of coping. J Health Soc Behav 19: 2–21. [PubMed] [Google Scholar]
  71. Peterson RA, Reiss S (1992). Anxiety Sensitivity Index. Worthington, OH: International Daignostic Systems Publishing Corporation. [Google Scholar]
  72. Piccinelli M, Wilkinson G (1994). Outcome of depression in psychiatric settings. Br J Psychiatry 164: 297–304. [DOI] [PubMed] [Google Scholar]
  73. Pollack MH, Otto MW (1997). Long‐term course and outcome of panic disorder. J Clin Psychiatry Suppl 58(2): 57–60. [PubMed] [Google Scholar]
  74. Roy‐Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC (2000). Lifetime panic‐depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help‐seeking. Br J Psychiatry 176: 229–35. [DOI] [PubMed] [Google Scholar]
  75. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26: 477–86. [DOI] [PubMed] [Google Scholar]
  76. Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU (1996). Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 38–43. [PubMed] [Google Scholar]
  77. Sheehan TJ, DeChello LM, Garcia R, Fifield J, Rothfield N, Reisine S (2001). Measuring disability: application of the Rasch model to activities of daily living (ADL/IADL). J Outcome Meas 5: 839–63. [PubMed] [Google Scholar]
  78. Sixma HJ, Kerssens JJ, Campen CV, Peters L (1998). Quality of care from the patients' perspective: from theoretical concept to a new measuring instrument. Health Expect 1: 82–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A (2006). Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 9: 193–200. [PubMed] [Google Scholar]
  80. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA (2002). Duration of major depressive episodes in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 181: 208–13. [DOI] [PubMed] [Google Scholar]
  81. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA (2004). Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 81: 231–40. [DOI] [PubMed] [Google Scholar]
  82. Stansfeld S, Marmot M (1992). Deriving a survey measure of social support: the reliability and validity of the Close Persons Questionnaire. Soc Sci Med 35: 1027–35. [DOI] [PubMed] [Google Scholar]
  83. Suh T, Gallo JJ (1997). Symptom profiles of depression among general medical service users compared with specialty mental health service users. Psychol Med 27: 1051–63. [DOI] [PubMed] [Google Scholar]
  84. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta‐analysis. Am J Psychiatry 157: 1552–62. [DOI] [PubMed] [Google Scholar]
  85. Terluin B, van Marwijk HW, Ader HJ, de Vet HC, Penninx BW, Hermens ML, Van Boeijen CA, Van Balkom AJ, Van Der Klink JJ, Stalman WA (2006). The Four‐Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self‐report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 6: 34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. van Balkom AJ, Beekman AT, de BE, Deeg DJ, Van DR, Van TW (2000). Comorbidity of the anxiety disorders in a community‐based older population in the Netherlands. Acta Psychiatr Scand 101: 37–45. [DOI] [PubMed] [Google Scholar]
  87. van den Heuvel OA, Groenewegen HJ, Barkhof F, Lazeron RH, Van Dyck R, Veltman DJ (2003). Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task. Neuroimage 18: 367–74. [DOI] [PubMed] [Google Scholar]
  88. van der Does W (2002). Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther 40: 105–20. [DOI] [PubMed] [Google Scholar]
  89. Vollebergh WA, Iedema J, Bijl RV, De GR, Smit F, Ormel J (2001). The structure and stability of common mental disorders: the NEMESIS study. Arch Gen Psychiatry 58: 597–603. [DOI] [PubMed] [Google Scholar]
  90. Vollrath M, Angst J (1989). Outcome of panic and depression in a seven‐year follow‐up: results of the Zurich study. Acta Psychiatr Scand 80: 591–6. [DOI] [PubMed] [Google Scholar]
  91. Wacker HR, Battegay R, Mullejans R, Schlosser C (2006). Using the CIDI‐C in the general population In Stefanis CN, Rabavilas AD, Soldatos CR. (eds) Psychiatry: A World Perspective. Amsterdam: Elsevier Science Publishers, pp. 138–43. [Google Scholar]
  92. Wang PS, Aguilar‐Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, De Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada‐Villa J, Seedat S, Wells JE (2007). Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 370: 841–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCormick RA (1995). Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 104: 3–14. [DOI] [PubMed] [Google Scholar]
  94. Wittchen HU (1994). Reliability and validity studies of the WHO – Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28: 57–84. [DOI] [PubMed] [Google Scholar]
  95. Wittchen HU, Burke JD, Semler G, Pfister H, Von CM, Zaudig M (1989). Recall and dating of psychiatric symptoms. Test‐retest reliability of time‐related symptom questions in a standardized psychiatric interview. Arch Gen Psychiatry 46: 437–43. [DOI] [PubMed] [Google Scholar]
  96. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D (1991). Cross‐cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The multicentre WHO/ADAMHA field trials. Br J Psychiatry 159: 645–53, 658. [DOI] [PubMed] [Google Scholar]
  97. Wust S, Wolf J, Hellhammer DH, Federenko I, Schommer N, Kirschbaum C (2000). The cortisol awakening response – normal values and confounds. Noise Health 2000; 2: 79–88. [PubMed] [Google Scholar]

Articles from International Journal of Methods in Psychiatric Research are provided here courtesy of Wiley

RESOURCES